The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
p53 polymorphisms: cancer implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“i1 i2 i3 i4 i5 i6 i7 i8 i9 i10 (41, 10,739) (1, 115) (2, 92) (5, 775) (2, 81) (4, 567) (7, 342) (1, 92) (13, 2,817) (5, 919) Transactivation domains Prolinerich domain DNA-binding domain Tetramerization domain”
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Self-citationVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“i1 i2 i3 i4 i5 i6 i7 i8 i9 i10 (41, 10,739) (1, 115) (2, 92) (5, 775) (2, 81) (4, 567) (7, 342) (1, 92) (13, 2,817) (5, 919) Transactivation domains Prolinerich domain DNA-binding domain Tetramerization domain”
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,481
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“Although a complete lack of MDM2 in Mdm2 −/− mice is embryonic letha”
BackgroundMicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Tay, Y., Zhang, J., Thomson, A. M., Lim, B., & Rigoutsos, I. (2008) · Nature · doi:10.1038/nature07299 · Cited by 1,385
DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., Gasco, M., Garrone, O., Crook, T., & Ryan, K. M. (2006) · Cell · doi:10.1016/j.cell.2006.05.034 · Cited by 1,380
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 1×
“Although a complete lack of MDM2 in Mdm2 −/− mice is embryonic letha”
BackgroundHung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
Dumont, P., Leu, J. I.-J., Della Pietra, A. C., George, D. L., & Murphy, M. (2003) · Nature Genetics · doi:10.1038/ng1093 · Cited by 1,273
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,079
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 901
Multiple loci identified in a genome-wide association study of prostate cancer
Thomas, G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.91 · Cited by 900
Kato, S., Han, S.-Y., Liu, W., Otsuka, K., Shibata, H., Kanamaru, R., & Ishioka, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431692100 · Cited by 874
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L. T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J. T., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1999 · Cited by 864
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression
Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., & Xu, Y. (2005) · Nature Cell Biology · doi:10.1038/ncb1211 · Cited by 859
Multiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2064 · Cited by 786
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Maximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
Central role of p53 in the suntan response and pathologic hyperpigmentation
Cui, R., Widlund, H. R., Feige, E., Lin, J. Y., Wilensky, D. L., Igras, V. E., D'Orazio, J., Fung, C. Y., Schanbacher, C. F., Granter, S. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.045 · Cited by 657
Tenesa, A., Farrington, S. M., Prendergast, J. G. D., Porteous, M. E., Walker, M., Haq, N., Barnetson, R. A., Theodoratou, E., Cetnarskyj, R., Cartwright, N., et al. (2008) · Nature Genetics · doi:10.1038/ng.133 · Cited by 597
Self-citationmiR-148 targets human DNMT3b protein coding region
Duursma, A. M., Kedde, M., Schrier, M., le Sage, C., & Agami, R. (2008) · RNA · doi:10.1261/rna.972008 · Cited by 577
The CORGI Consortium, Tomlinson, I. P., The EPICOLON Consortium, Webb, E., Carvajal-Carmona, L., Broderick, P., Howarth, K., Pittman, A. M., Spain, S., Lubbe, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.111 · Cited by 562
Self-citationPUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., & Green, D. R. (2005) · Science · doi:10.1126/science.1114297 · Cited by 546
Murray-Zmijewski, F., Lane, D. P., & Bourdon, J.-C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 523
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
Marin, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O'Nions, J., Tidy, J. A., James, N., McGregor, J. M., Harwood, C. A., Yulug, I. G., et al. (2000) · Nature Genetics · doi:10.1038/75586 · Cited by 515
Primary structure polymorphism at amino acid residue 72 of human p53.
Matlashewski, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J., & Crawford, L. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.961 · Cited by 497
Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis
Gottlieb, T. M., Leal, J. F. M., Seger, R., Taya, Y., & Oren, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205181 · Cited by 472
Identification of a novel p53 functional domain that is necessary for efficient growth suppression
Walker, K. K., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15335 · Cited by 471
Association studies for finding cancer-susceptibility genetic variants
Pharoah, P. D. P., Dunning, A. M., Ponder, B. A. J., & Easton, D. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1476 · Cited by 462
Self-citationArginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y., & Shkedy, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14973 · Cited by 461
Godar, S., Ince, T. A., Bell, G. W., Feldser, D., Donaher, J. L., Bergh, J., Liu, A., Miu, K., Watnick, R. S., Reinhardt, F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.006 · Cited by 456
Dumaz, N., & Meek, D. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7002 · Cited by 455
Bergamaschi, D., Gasco, M., Hiller, L., Sullivan, A., Syed, N., Trigiante, G., Yulug, I., Merlano, M., Numico, G., Comino, A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00079-5 · Cited by 449
p53 regulates maternal reproduction through LIF
Hu, W., Feng, Z., Teresky, A. K., & Levine, A. J. (2007) · Nature · doi:10.1038/nature05993 · Cited by 445
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Song, H., Hollstein, M., & Xu, Y. (2007) · Nature Cell Biology · doi:10.1038/ncb1571 · Cited by 439
Self-citationTumor susceptibility of p21(Waf1/Cip1)-deficient mice.
Martín‐Caballero, J., Flores, J. M., García, P., & Serrano, M. (2001) · PubMed · Cited by 429
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418
The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 414
p53 suppresses the self-renewal of adult neural stem cells
Meletis, K., Wirta, V., Hede, S.-M., Nistér, M., Lundeberg, J., & Frisén, J. (2006) · Development · doi:10.1242/dev.02208 · Cited by 413
p53 polymorphic variants at codon 72 exert different effects on cell cycle progression
Pim, D., & Banks, L. (2004) · International Journal of Cancer · doi:10.1002/ijc.11548 · Cited by 408
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A., & Bradley, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15608 · Cited by 386
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K. P., & Xiao, Z.-X. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 383
Garcia-Closas, M., Hall, P., Nevanlinna, H., Pooley, K., Morrison, J., Richesson, D. A., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Arias, J. I., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000054 · Cited by 378
Self-citationErster, S., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 368
ATM and ataxia telangiectasia: Second in Molecular Medicine Review Series
McKinnon, P. J. (2004) · EMBO reports · doi:10.1038/sj.embor.7400210 · Cited by 366
Is p53 Polymorphism Maintained by Natural Selection?
Beckman, G., Birgander, R., Själander, A., Saha, N., Holmberg, P. Å., Kivelä, A., & Beckman, L. (1994) · Human Heredity · doi:10.1159/000154228 · Cited by 362
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352
The polyproline region of p53 is required to activate apoptosis but not growth arrest
Sakamuro, D., Sabbatini, P., White, E., & Prendergast, G. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201263 · Cited by 316
MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
Bond, G., Hu, W., & Levine, A. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332627 · Cited by 308
The p53 family in differentiation and tumorigenesis
Stiewe, T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2072 · Cited by 306
Mortality and Cancer Incidence in 263 Patients With Ataxia-Telangiectasia 2
(1986) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/77.1.89 · Cited by 305
Bensaad, K., & Vousden, K. H. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.04.004 · Cited by 305
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0180 · Cited by 287
A polymorphic microsatellite that mediates induction of PIG3 by p53
Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M. (2002) · Nature Genetics · doi:10.1038/ng836 · Cited by 274
p16INK4a Translation Suppressed by miR-24
Lal, A., Kim, H. H., Abdelmohsen, K., Kuwano, Y., Pullmann, R., Srikantan, S., Subrahmanyam, R., Martindale, J. L., Yang, X., Ahmed, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001864 · Cited by 268 · cited 1×
“The recent finding that microRNAs (miRNAs) can inhibit translation by targeting the coding sequences of genes invites speculation that there are as yet undiscovered miRNAs that can target p53 in a similar fashion, which might explain how silent TP53 polymorphisms in the coding region of the gene could influence p53 ac…”
BackgroundRegulation of p53 responses by post-translational modifications
Xu, Y. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401182 · Cited by 265
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260
Bergamaschi, D., Samuels, Y., Sullivan, A., Zvelebil, M., Breyssens, H., Bisso, A., Del Sal, G., Syed, N., Smith, P., Gasco, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1879 · Cited by 259
The Breast Cancer Association Consortium (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj374 · Cited by 258
Tomita, Y., Marchenko, N., Erster, S., Nemajerova, A., Dehner, A., Klein, C., Pan, H., Kessler, H., Pancoska, P., & Moll, U. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507611200 · Cited by 248
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
Sullivan, A., Syed, N., Gasco, M., Bergamaschi, D., Trigiante, G., Attard, M., Hiller, L., Farrell, P. J., Smith, P., Lu, X., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207428 · Cited by 247
NAD(P)H:Quinone Oxidoreductase 1 (NQO1, DT-Diaphorase), Functions and Pharmacogenetics
Ross, D., & Siegel, D. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)82008-1 · Cited by 245
p53 and its isoforms in cancer
Bourdon, J.-C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603886 · Cited by 245
p53 mRNA controls p53 activity by managing Mdm2 functions
Candeias, M. M., Malbert-Colas, L., Powell, D. J., Daskalogianni, C., Maslon, M. M., Naski, N., Bourougaa, K., Calvo, F., & Fåhraeus, R. (2008) · Nature Cell Biology · doi:10.1038/ncb1770 · Cited by 241
Spring, K., Ahangari, F., Scott, S. P., Waring, P., Purdie, D. M., Chen, P. C., Hourigan, K., Ramsay, J., McKinnon, P. J., Swift, M., et al. (2002) · Nature Genetics · doi:10.1038/ng958 · Cited by 237
Common sequence variants on 20q11.22 confer melanoma susceptibility
Brown, K. M., MacGregor, S., Montgomery, G. W., Craig, D. W., Zhao, Z. Z., Iyadurai, K., K Henders, A., Homer, N., Campbell, M. J., Stark, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.163 · Cited by 223
Gemignani, F., Moreno, V., Landi, S., Moullan, N., Chabrier, A., Gutiérrez-Enríquez, S., Hall, J., Guino, E., Peinado, M. A., Capella, G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207305 · Cited by 217
Bougeard, G., Baert-Desurmont, S., Tournier, I., Vasseur, S., Martin, C., Brugieres, L., Chompret, A., Bressac-de Paillerets, B., Stoppa-Lyonnet, D., Bonaiti-Pellie, C., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.037952 · Cited by 217
Tumor suppression and normal aging in mice with constitutively high p53 activity
Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210
Fagerholm, R., Hofstetter, B., Tommiska, J., Aaltonen, K., Vrtel, R., Syrjäkoski, K., Kallioniemi, A., Kilpivaara, O., Mannermaa, A., Kosma, V.-M., et al. (2008) · Nature Genetics · doi:10.1038/ng.155 · Cited by 208
Variation in the human TP53 gene affects old age survival and cancer mortality
van Heemst, D., Mooijaart, S. P., Beekman, M., Schreuder, J., de Craen, A. J. M., Brandt, B. W., Eline Slagboom, P., & Westendorp, R. G. J. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.001 · Cited by 206
Belteki, G., Gertsenstein, M., Ow, D. W., & Nagy, A. (2003) · Nature Biotechnology · doi:10.1038/nbt787 · Cited by 186
Wolff, S., Erster, S., Palacios, G., & Moll, U. M. (2008) · Cell Research · doi:10.1038/cr.2008.62 · Cited by 186
Mantovani, F., Tocco, F., Girardini, J. E., Smith, P., Gasco, M., Lü, X., Crook, T., & Sal, G. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1306 · Cited by 177
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li, Y., & Prives, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210311 · Cited by 174
SnapShot: p53 Posttranslational Modifications
Kruse, J.-P., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.05.020 · Cited by 170
Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex
Tidow, H., Melero, R., Mylonas, E., Freund, S. M. V., Grossmann, J. G., Carazo, J. M., Svergun, D. I., Valle, M., & Fersht, A. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705069104 · Cited by 170
Zhang, X., Miao, X., Guo, Y., Tan, W., Zhou, Y., Sun, T., Wang, Y., & Lin, D. (2005) · Human Mutation · doi:10.1002/humu.20277 · Cited by 168
Recent advances in p53 research: an interdisciplinary perspective
Olivier, M., Petitjean, A., Marcel, V, Pétré, A., Mounawar, M., Plymoth, A., de Fromentel, C. C., & Hainaut, P. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2008.69 · Cited by 161
p53 and the Li-Fraumeni syndrome
Malkin, D. M. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90233-c · Cited by 155
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis
Matakidou, A., Eisen, T., & Houlston, R. S. (2003) · Mutagenesis · doi:10.1093/mutage/geg008 · Cited by 151
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
Tabori, U. Y., Nanda, S., Druker, H. A., Lees, J., & Malkin, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3682 · Cited by 151
Craig, A. L., Burch, L. R., VOJTESEK, B., MIKUTOWSKA, J., Thompson, A. M., & Hupp, T. R. (1999) · Biochemical Journal · doi:10.1042/bj3420133 · Cited by 149
Resnick, M. A., & Inga, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633803100 · Cited by 149
Association of Breast Cancer Outcome With Status of p53 and MDM2 SNP309
Boersma, B. J., Howe, T. M., Goodman, J. E., Yfantis, H. G., Lee, D. H., Chanock, S. J., & Ambs, S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj245 · Cited by 148
Lind, H., Zienolddiny, S., Ekstrøm, P. O., Skaug, V., & Haugen, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21872 · Cited by 144
Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2
Kuznetsov, S. G., Liu, P., & Sharan, S. K. (2008) · Nature Medicine · doi:10.1038/nm.1719 · Cited by 144
Caulín, C., Nguyen, T., Lang, G. A., Goepfert, T. M., Brinkley, B. R., Cai, W., Lozano, G., & Roop, D. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31721 · Cited by 144
P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literature
Zhou, Y., Li, N., Zhuang, W., Liu, G., Wu, T., Yao, X., Du, L., Wei, M., & Wu, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.22833 · Cited by 142
Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
Chao, C., Hergenhahn, M., Kaeser, M. D., Wu, Z., Saito, S., Iggo, R., Hollstein, M., Appella, E., & Xu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306938200 · Cited by 141
Self-citationSer46 Phosphorylation Regulates p53-Dependent Apoptosis and Replicative Senescence
Feng, L., Hollstein, M., & Xu, Y. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3526 · Cited by 140
Self-citationLuo, J., Yang, Q., Tong, W., Hergenhahn, M., Wang, Z., & Hollstein, M. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204080 · Cited by 135
Self-citationTrp53-dependent DNA-repair is affected by the codon 72 polymorphism
Siddique, M. M., & Sabapathy, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209405 · Cited by 129
Ørsted, D. D., Bojesen, S. E., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062476 · Cited by 122
Comparative analysis of cancer genes in the human and chimpanzee genomes
Puente, X. S., Velasco, G., Gutiérrez‐Fernández, A., Bertranpetit, J., King, M., & López-Otín, C. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-15 · Cited by 122
The Codon 47 Polymorphism in p53 Is Functionally Significant
Li, X., Dumont, P., Pietra, A. D., Shetler, C. M., & Murphy, M. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414637200 · Cited by 119
p53 and the Li-Fraumeni syndrome
Malkin, D. M. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90014-0 · Cited by 116
Costa, S., Pinto, D., Pereira, D., Rodrigues, H., Cameselle‐Teijeiro, J., Medeiros, R., & Schmitt, F. C. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-32 · Cited by 114
Hu, W., Feng, Z., Ma, L., Wagner, J., Rice, J. J., Stolovitzky, G. A., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2656 · Cited by 114
Global Analysis of ATM Polymorphism Reveals Significant Functional Constraint
Thorstenson, Y. R., Shen, P., Tusher, V. G., Wayne, T. L., Davis, R. W., Chu, G., & Oefner, P. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321296 · Cited by 108
Ruijs, M., Schmidt, M. K., Nevanlinna, H. A., Tommiska, J., Aittomäki, K., Pruntel, R., Verhoef, S., & Veer, L. J. V. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201715 · Cited by 108
Shen, H., Zheng, Y., Sturgis, E. M., Spitz, M. R., & Wei, Q. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00117-9 · Cited by 107
Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.
Felley‐Bosco, E., Weston, A., Cawley, H., Bennett, W. P., & Harris, C. C. (1993) · Europe PMC (PubMed Central) · Cited by 104
p53 protein variants: structural and functional similarities with p63 and p73 isoforms
Courtois-Cox, S., de Fromentel, C. C., & Hainaut, P. L. (2004) · Oncogene · doi:10.1038/sj.onc.1206929 · Cited by 102
Xu, Y., Yao, L., Ouyang, T., Li, J., Wang, T., Fan, Z., Lin, B., Lu, Y., & Xie, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0507 · Cited by 102
Some p53-binding proteins that can function as arbiters of life and death
Braithwaite, A. W., Sal, G. D., & Lü, X. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401924 · Cited by 96
Mdmx and Mdm2: Brothers in Arms?
Marine, J., & Jochemsen, A. G. (2004) · Cell Cycle · doi:10.4161/cc.3.7.998 · Cited by 95
Chedid, M., Michieli, P., Lengel, C. R., Huppi, K. E., & Givol, D. (1994) · PubMed · Cited by 95
Kakudo, Y., Shibata, H., Otsuka, K., Kato, S., & Ishioka, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2935 · Cited by 90
Tomso, D. J., Inga, A., Menéndez, D., Pittman, G. S., Campbell, M. R., Storici, F., Bell, D. A., & Resnick, M. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501721102 · Cited by 84
Chen, K., Hu, Z., Wang, L., Sturgis, E. M., El‐Naggar, A. K., Zhang, W., & Wei, Q. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm172 · Cited by 83
Detection of functional single-nucleotide polymorphisms that affect apoptosis
Harris, S. L., Gil, G. A., Robins, H. S., Hu, W., Hirshfield, K. M., Bond, E. E., Bond, G. L., & Levine, A. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508390102 · Cited by 83
Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2297-2308.2006 · Cited by 81
p53: A new player in reproduction
Hu, W., Feng, Z., Atwal, G. S., & Levine, A. J. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5658 · Cited by 79
p53Codon 72 andp21Codon 31 Polymorphisms in Prostate Cancer
Huang, S., Wu, W., Chang, W. W., Wu, M., Chen, Y., Chen, Y., Yu, C., Wu, T. T.-L., Lee, Y.-H., Huang, J., et al. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2217.13.12 · Cited by 79
Polymorphism p53 codon‐72 and invasive cervical cancer: a meta‐analysis
Jee, S. H., Won, S. Y., Yun, J. E., Lee, J. E., Park, J. S., & Ji, S. S. (2003) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2003.08.017 · Cited by 77
Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53
Medrano, S., Burns‐Cusato, M., Atienza, M., Rahimi, D., & Scrable, H. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.016 · Cited by 76
Vikhanskaya, F., Siddique, M. M., Lee, M. K., Broggini, M., & Sabapathy, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1547 · Cited by 75
p53 Proteasomal Degradation: Poly-Ubiquitination is Not the Whole Story
Asher, G., & Shaul, Y. (2005) · Cell Cycle · doi:10.4161/cc.4.8.1900 · Cited by 74
Haplotype structure and selection of the MDM2 oncogene in humans
Atwal, G. S., Bond, G. L., Metsuyanim, S., Papa, M. Z., Friedman, E., Distelman-Menachem, T., Ben‐Asher, E., Lancet, D., Ross, D. A., Sninsky, J. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610998104 · Cited by 69
Wang‐Gohrke, S., Weikel, W., Risch, H. A., Vesprini, D., Abrahamson, J., Lerman, C., Godwin, A. K., Moslehi, R., Olipade, O., Brunet, J., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690669 · Cited by 67
TP53 mutation, allelism and survival in non-small cell lung cancer
Nelson, H. H., Wilkojmen, M., Marsit, C. J., & Kelsey, K. T. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi125 · Cited by 66
Salvioli, S., Bonafè, M., Barbi, C., Storci, G., Trapassi, C., Tocco, F., Gravina, S., Rossi, M., Tiberi, L., Mondello, C., et al. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1978 · Cited by 58
Lum, S. S., Chua, H. W., Li, H., Li, W., Rao, N., Wei, J., Shao, Z., & Sabapathy, K. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn024 · Cited by 52
Tan, X., Popanda, O., Ambrosone, C. B., Kropp, S., Helmbold, I., von Fournier, D., Haase, W., Sautter-Bihl, M. L., Wenz, F. K., Schmezer, P., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9119-2 · Cited by 51
Sun, Y., Hildesheim, A., Li, H., Li, Y., Chen, J. Y., Cheng, Y. J., Hayes, R. B., Rothman, N., Bi, W., & Cao, Y. (1995) · PubMed · Cited by 50
Restle, A., Färber, M., Baumann, C., Böhringer, M., Scheidtmann, K. H., Müller-Tidow, C., & Wiesmüller, L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn503 · Cited by 49
Toledo, F., Lee, C. J., Krummel, K. A., Rodewald, L.-W., Liu, C.-W., & Wahl, G. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00999-06 · Cited by 46
Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72
Reinbold, M., Luo, J.-L., Nedelko, T., Jerchow, B., Murphy, M. E., Whibley, C. E., Wei, Q., & Hollstein, M. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210932 · Cited by 43
Self-citationZawlik, I., Kita, D., Vaccarella, S., Mittelbronn, M. G. A., Franceschi, S., & Ohgaki, H. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00170.x · Cited by 40
Roth, J. C., Koch, P., Contente, A., & Dobbelstein, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203500 · Cited by 38
Association of common ATMvariants with familial breast cancer in a South American population
González‐Hormazábal, P., Bravo, T., Blanco, R., Valenzuela, C. Y., Gómez, F., Waugh, E., Peralta, O., Ortuzar, W. I., Reyes, J. M., & Lilian Jara, S. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-117 · Cited by 37
RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analyses
Toledo, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl518 · Cited by 35
Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer
Jun, H. J., Park, S. H., Lee, W. K., Choi, J. E., Jang, J. S., Kim, E., Ick, S., Kim, D. S., Kam, S., Kim, C. H., et al. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20279 · Cited by 30
Kurihara, A., Nagoshi, H., Yabuki, M., Okuyama, R., Obinata, M., & Ikawa, S. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01097.x · Cited by 27
Bahassi, E. M., Penner, C. G., Robbins, S. B., Tichy, E. D., Feliciano, E., Yin, M., Liang, L., Deng, L., Tischfield, J. A., & Stambrook, P. J. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.11.025 · Cited by 26
An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients
Atwal, G. S., Rabadán, R., Lozano, G., Strong, L. C., Ruijs, M., Schmidt, M. K., Veer, L. J. V., Nevanlinna, H. A., Tommiska, J., Aittomäki, K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001951 · Cited by 25
Role in tumorigenesis of silent mutations in the TP53 gene
Strauss, B. S. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00135-4 · Cited by 25
Comprehensive assessment of P21 polymorphisms and lung cancer risk
Choi, Y. Y., Kang, H.-K., Choi, J. E., Jang, J. S., Kim, E. J., Ick, S., Lee, W. K., Kam, S., Kim, C. H., Han, S. B., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0222-6 · Cited by 25
Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene
Dudgeon, C., Kek, C., Demidov, O. N., Saito, S., Fernandes, K., Diot, A., Bourdon, J., Lane, D. P., Appella, E., Fornace, A. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2063 · Cited by 25
Sansone, P., Storci, G., Pandolfi, S., Montanaro, L., Chieco, P., & Bonafè, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603723 · Cited by 22
Effect of the p53 Codon 72 and Intron 3Polymorphisms on Non-Small Cell Lung Cancer (NSCLC) Prognosis
Boldrini, L., Gisfredi, S., Ursino, S., Lucchi, M., Greco, G., Mussi, A., Donati, V. L., & Fontanini, G. (2008) · Cancer Investigation · doi:10.1080/07357900701788023 · Cited by 22
Matakidou, A., Galta, R. E., Webb, E. L., Rudd, M. F., Bridle, H. L., Eisen, T. G., & Houlston, R. S. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.02.021 · Cited by 18
The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer
Staalesen, V., Knappskog, S., Chrisanthar, R., Nord, S., Løkkevik, E., Anker, G. B., Østenstad, B., Lundgren, S., Risberg, T., Mjaaland, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2822 · Cited by 16
Gorgoulis, V. G., Liloglou, T., Sigala, F., Korkolis, D. P., Yannoukakos, D., Papalambros, E. L., Asimacopoulos, P. J., Papavassiliou, A. G., & Kotsinas, A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.008 · Cited by 14
Association of the PIG3 Promoter Polymorphism with Invasive Bladder Cancer in a Japanese Population
Ito, M., Nishiyama, H., Watanabe, J., Kawanishi, H., Takahashi, T., Kamoto, T., Habuchi, T., & Ogawa, O. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi225 · Cited by 12
(1995) · PubMed
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Cited by
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Self-citationThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Genetic variation in microRNA networks: the implications for cancer research
Ryan, B. M., Robles, A. I., & Harris, C. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2867 · Cited by 1,257
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Metadata
- Authors
- Whibley, C., Pharoah, P. D. P., & Hollstein, M.
- Venue
- Nature Reviews Cancer
- Published
- 2009-02
- Volume
- 9
- Issue
- 2
- Pages
- 95-107
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2057854840
- Cited by
- 665
- References
- 171
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.